Investor Relations
On September 28, 2021, PNP entered into an Assignment and License Agreement with GeoVax, Inc., whereby GeoVax obtained an exclusive license to PNP’s intellectual property and related assets associated with Gedeptin®. All inquiries concerning Gedeptin® should now be directed to GeoVax.